Real World Utilization of Upadacitinib in Adult and Adolescent Patients Living With Moderate to Severe Atopic Dermatitis (AD-VISE)
Real World Utilization of Upadacitinib in Adult and Adolescent Patients Living With Moderate to Severe Atopic Dermatitis (AD-VISE)
Atopic dermatitis (AD; also known as atopic eczema) is an inflammatory skin disease. The safety and effectiveness of upadacitinib for AD has been well-documented in previous studies, however, important information is missing on the use patterns and outcomes with upadacitinib in a real-world setting. Therefore, the purpose of this observational study is to help inform real-world usage patterns regarding the safety and effectiveness and duration of response of upadacitinib in adolescent and adult AD participants >=12 years old in the real-world setting.
Upadacitinib is an approved drug being developed for the treatment of AD. Around 975 adolescent and adult participants who are prescribed upadacitinib for the treatment of AD in routine clinical practice will be enrolled worldwide.
Participants will receive oral upadacitinib as prescribed by their physician. Data from these participants will be collected for approximately 2 years.
There will be no additional burden for participants in this trial compared to their standard of care. Participants will attend regular visits during the course of the study at a hospital or clinic and will be asked to provide additional information by questionnaire at each visit.
Inclusion Criteria:
Exclusion Criteria:
- Participants who are currently participating in interventional research (not including non-interventional study, post-marketing observational study, or registry participation).
Ciudad Autonoma de Buenos Aire, Buenos Aires F.D. 1055, Argentina
Ciudad Autonoma de Buenos Aire, Buenos Aires F.D. 1425, Argentina
Ciudad Autonoma de Buenos Aire, Buenos Aires F.D. 1425, Argentina
CABA, C1199ABB, Argentina
Greater Sudbury, Ontario P3C 1X3, Canada
Hamilton, Ontario L8L 3C3, Canada
North York, Ontario M3B 3S6, Canada
Richmond Hill, Ontario L4B 1L1, Canada
St-Jean Sur Le Richelieu, Quebec J3A 1B5, Canada
Prague, Central Bohemia 180 81, Czechia
Amaroussio, Attica 15123, Greece
Thessaloniki, Evrytania 54643, Greece
Thessaloniki, Evrytania 54643, Greece
Pecs, Nógrád megye 7624, Hungary
Cava de' Tirreni, Salerno 84013, Italy
Guadalajara, Jalisco 44130, Mexico
Mexico City, Mexico City 14050, Mexico
Oaxaca City, Oaxaca 68000, Mexico
San Andrés Cholula, Puebla 72820, Mexico
Mexico City, 11650, Mexico
Cracow, Lesser Poland Voivodeship 30-383, Poland
Lublin, Lublin Voivodeship 20-573, Poland
Warsaw, Masovian Voivodeship 02-507, Poland
Chelyabinsk, Chelyabinsk Oblast 454048, Russia
Petrozavodsk, Kursk Oblast 185019, Russia
Moscow, Moscow 115522, Russia
Ryazan, Ryazan Oblast 390029, Russia
Stavropol, Stavropol Kray 355000, Russia
San Cristóbal de La Laguna, Santa Cruz de Tenerife 38320, Spain
Santa Cruz de Tenerife, Santa Cruz de Tenerife 38010, Spain
Kaohsiung City, Keelung 807, Taiwan
Taipei City, Taipei 100, Taiwan